Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 16/20 | 0.80 |
| ▸ | HTR1D | P28221 | 15/20 | 0.80 |
| ▸ | HTR1A | P08908 | 4/20 | 0.48 |
| ▸ | GHSR | Q92847 | 1/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.37 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6603438 | 1.00 | HTR1B (0.80) | HTR1BHTR1DHTR1AGHSRP2RX7 | |
| SCHEMBL6604882 | 0.92 | HTR1B (0.81) | HTR1BHTR1DHTR1AGHSRP2RX7 | |
| SCHEMBL6604879 | 0.92 | HTR1B (0.81) | HTR1BHTR1DHTR1AGHSRP2RX7 | |
| SCHEMBL6604234 | 0.89 | HTR1B (1.00) | HTR1BHTR1DHTR1AGHSR | |
| SCHEMBL6604237 | 0.89 | HTR1B (1.00) | HTR1BHTR1DHTR1AGHSR | |
| SCHEMBL6603902 | 0.81 | HTR1B (0.66) | HTR1BHTR1DHTR1AGHSRP2RX7 | |
| SCHEMBL6603907 | 0.81 | HTR1B (0.66) | HTR1BHTR1DHTR1AGHSRP2RX7 | |
| SCHEMBL6606319 | 0.81 | HTR1B (0.86) | HTR1BHTR1DHTR1AGHSR | |
| SCHEMBL6606314 | 0.81 | HTR1B (0.86) | HTR1BHTR1DHTR1AGHSR | |
| SCHEMBL6604091 | 0.81 | HTR1B (0.65) | HTR1BHTR1DHTR1AGHSRP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1216239-B1 | PIPERAZINE DERIVATIVES AS 5-HT1B ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 2004-02-11 | — | — | EP | claimed |
| WO-2020183011-A1 | HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER | INSTITUT CURIE (FR) | 2020-09-17 | — | — | WO | disclosed |
| EP-1216239-B1 | PIPERAZINE DERIVATIVES AS 5-HT1B ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 2004-02-11 | — | — | EP | disclosed |